Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

Cora N Sternberg; Robert E Hawkins; John Wagstaff; Pamela Salman; Jozef Mardiak; Carlos H Barrios; Juan J Zarba; Oleg A Gladkov; E. Lee; Cezary Szczylik; L. McCann; S. D. Rubin; M. Chen; I. D. Davis

doi:10.1016/j.juro.2013.08.043

Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

Cora N Sternberg, Robert E Hawkins, John Wagstaff, Pamela Salman, Jozef Mardiak, Carlos H Barrios, Juan J Zarba, Oleg A Gladkov, E. Lee, Cezary Szczylik, L. McCann, S. D. Rubin, M. Chen, I. D. Davis

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	2017
Number of pages	1
Journal	Journal of Urology
Volume	190
Issue number	6
DOIs	https://doi.org/10.1016/j.juro.2013.08.043
Publication status	Published - Dec 2013
Externally published	Yes

Access to Document

10.1016/j.juro.2013.08.043

Cite this

Sternberg, C. N., Hawkins, R. E., Wagstaff, J., Salman, P., Mardiak, J., Barrios, C. H., Zarba, J. J., Gladkov, O. A., Lee, E., Szczylik, C., McCann, L., Rubin, S. D., Chen, M., & Davis, I. D. (2013). Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update. Journal of Urology, 190(6), 2017. https://doi.org/10.1016/j.juro.2013.08.043

Sternberg, Cora N ; Hawkins, Robert E ; Wagstaff, John ; Salman, Pamela ; Mardiak, Jozef ; Barrios, Carlos H ; Zarba, Juan J ; Gladkov, Oleg A ; Lee, E. ; Szczylik, Cezary ; McCann, L. ; Rubin, S. D. ; Chen, M. ; Davis, I. D. / Re : A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update. In: Journal of Urology. 2013 ; Vol. 190, No. 6. pp. 2017.

@article{b6307c119ec048688b8c3a6b92467c9c,

title = "Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update",

author = "Sternberg, {Cora N} and Hawkins, {Robert E} and John Wagstaff and Pamela Salman and Jozef Mardiak and Barrios, {Carlos H} and Zarba, {Juan J} and Gladkov, {Oleg A} and E. Lee and Cezary Szczylik and L. McCann and Rubin, {S. D.} and M. Chen and Davis, {I. D.}",

year = "2013",

month = dec,

doi = "10.1016/j.juro.2013.08.043",

language = "English",

volume = "190",

pages = "2017",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "American Urological Association",

number = "6",

}

Sternberg, CN, Hawkins, RE, Wagstaff, J, Salman, P, Mardiak, J, Barrios, CH, Zarba, JJ, Gladkov, OA, Lee, E, Szczylik, C, McCann, L, Rubin, SD, Chen, M & Davis, ID 2013, 'Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update', Journal of Urology, vol. 190, no. 6, pp. 2017. https://doi.org/10.1016/j.juro.2013.08.043

Re : A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update. / Sternberg, Cora N; Hawkins, Robert E; Wagstaff, John; Salman, Pamela; Mardiak, Jozef; Barrios, Carlos H; Zarba, Juan J; Gladkov, Oleg A; Lee, E.; Szczylik, Cezary; McCann, L.; Rubin, S. D.; Chen, M.; Davis, I. D.

In: Journal of Urology, Vol. 190, No. 6, 12.2013, p. 2017.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Re

T2 - A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

AU - Sternberg, Cora N

AU - Hawkins, Robert E

AU - Wagstaff, John

AU - Salman, Pamela

AU - Mardiak, Jozef

AU - Barrios, Carlos H

AU - Zarba, Juan J

AU - Gladkov, Oleg A

AU - Lee, E.

AU - Szczylik, Cezary

AU - McCann, L.

AU - Rubin, S. D.

AU - Chen, M.

AU - Davis, I. D.

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84888624978&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2013.08.043

DO - 10.1016/j.juro.2013.08.043

M3 - Comment / Debate

C2 - 24209513

AN - SCOPUS:84888624978

VL - 190

SP - 2017

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -

Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

Access to Document

Other files and links

Cite this